Spoiler Alert: World Orphan Drug Congress, Geneva 2013

In Advocacy, Clinical Development, Market Access, Orphan Drug Congress, Partnering & Investment, Regulation & Government by Matt Turner

The secret is out. The unrivaled networking event for orphan drug developers is once again taking place in Geneva on the 14th-15th November 2013.

Whether you’re a previous attendee or still deciding which meeting to do business at this year, watch the video above and discover why industry executives responsible for commercialising their pipelines, are coming to maximise their business opportunities:

Remember, the World Orphan Drug Congress, Geneva 2013 is a networking conference endorsed by orphan drug developers, for orphan drug developers. Industry leaders use the World Orphan Drug Congress Europe to form key strategic partnerships and make vital contacts with European payers, National Rare Disease Alliances, patient groups and fellow peers.

Visit the website for more information

Delegate seats are limited so register today to guarantee your place.